Literature DB >> 21111732

Regulation of microRNA-145 by growth arrest and differentiation.

Gaspare La Rocca1, Bin Shi, Alessandra Audia, Giovanna Ferrari-Amorotti, Hestia S Mellert, Bruno Calabretta, Steven B McMahon, Laura Sepp-Lorenzino, Renato Baserga.   

Abstract

MicroRNA145 (miR145), a tumor suppressor miR, has been reported to inhibit growth of human cancer cells, to induce differentiation and to cause apoptosis, all conditions that result in growth arrest. In order to clarify the functional effects of miR145, we have investigated its expression in diverse conditions and different cell lines. Our results show that miR145 levels definitely increase in differentiating cells and also in growth-arrested cells, even in the absence of differentiation. Increased expression during differentiation sometimes occurs as a late event, suggesting that miR145 could be required either early or late during the differentiation process. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21111732     DOI: 10.1016/j.yexcr.2010.11.010

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  7 in total

1.  Serum microRNA-145 as a novel biomarker in human ovarian cancer.

Authors:  Huichao Liang; Zhipeng Jiang; Guie Xie; Yan Lu
Journal:  Tumour Biol       Date:  2015-02-27

2.  EGFR signals downregulate tumor suppressors miR-143 and miR-145 in Western diet-promoted murine colon cancer: role of G1 regulators.

Authors:  Hongyan Zhu; Urszula Dougherty; Victoria Robinson; Reba Mustafi; Joel Pekow; Sonia Kupfer; Yan Chun Li; John Hart; Kathleen Goss; Alessandro Fichera; Loren Joseph; Marc Bissonnette
Journal:  Mol Cancer Res       Date:  2011-06-08       Impact factor: 5.852

3.  Inhibitory effect of miR-145 on RPE cell proliferation.

Authors:  Ken Zhao; Zhen Chen; Xu-Dong Lv; Gang Dong; Huan Xia
Journal:  Am J Transl Res       Date:  2016-12-15       Impact factor: 4.060

Review 4.  Non-Coding RNAs in Retinoic Acid as Differentiation and Disease Drivers.

Authors:  Carlos García-Padilla; Estefanía Lozano-Velasco; Carmen López-Sánchez; Virginio Garcia-Martínez; Amelia Aranega; Diego Franco
Journal:  Noncoding RNA       Date:  2021-02-17

5.  NEDD9, a novel target of miR-145, increases the invasiveness of glioblastoma.

Authors:  Maria Carmela Speranza; Véronique Frattini; Federica Pisati; Dimos Kapetis; Paola Porrati; Marica Eoli; Serena Pellegatta; Gaetano Finocchiaro
Journal:  Oncotarget       Date:  2012-07

6.  Up-regulated miR-145 expression inhibits porcine preadipocytes differentiation by targeting IRS1.

Authors:  Yunxue Guo; Yaosheng Chen; Yun Zhang; Yue Zhang; Luxi Chen; Delin Mo
Journal:  Int J Biol Sci       Date:  2012-11-12       Impact factor: 6.580

7.  The expression of LEP, LEPR, IGF1 and IL10 in obesity and the relationship with microRNAs.

Authors:  Renata Viesti A Collares; Wilson Salgado; Daniela Pretti da Cunha Tirapelli; José Sebastião dos Santos
Journal:  PLoS One       Date:  2014-04-01       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.